REFERENCES

Arciniegas DB, Lauterbach EC, Anderson KE, et al. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectr. 2005;10: 1-14.

Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry. 2000; 5:209-306.

Bermack JE, Debonnel G. The role of sigma receptors in depression. J Pharmacol Sci. 2005; 97: 317-336.

Bittigau P, Ikonomidou C. Glutamate in neurologic diseases. J Child Neurol. 1997; 12: 471-485.

Black DW. Pathologicial laughter: a review of the literature. J Nerv Ment Dis. 1982; 170: 67-71.

Caroscio JT, Mulvihill MN, Sterling R, et al. Amyotrophic lateral sclerosis: its natural history. Neurol Clin. 1987;5:1-8.

Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006; 11:6(suppl 6):1-7.

Dark FL, McGrath JJ, Ron MA. Pathological laughing and crying. Aust N Z J Psychiatry. 1996; 30: 472-479.

Green RL. Regulation of affect. Semin Clin Neuropsychiatry. 1998;3:195-200.

Green RL, MCAllister TW, Bernat JL. A study in crying in medically and surgically hospitalized patients. Am J Psychiatry. 1987; 144: 442-447.

Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol. 1985;232:295-300.

Kaschka WP, Meyer A, Schier KR, et al. Treatment of pathological crying with citalopram. Pharmacopsychiatry. 2001;34:254-258.

Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology. 2000; 54: 1805-1810.

Kim JS, Choi S, Kwon SU, et al. Inability to control anger or aggression after stroke. Neurology. 2002;58:1106-1108.

Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 2003; 3: 65-94.

Minden SL, Schiffer RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol. 1990; 47:98-104.

Moore SR, Gresham LS, Bromberg MB, et al. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997;63:89-93. 

Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry. 1993; 150: 286-293.

Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci. 2005; 17: 447-454.

Shaibani  AT, Sabbagh MN, Doody R, Laughter and Crying in Neurologic Disorders. Neuropsychiatry Neurolphsycol Behave Neurol. 1994; 7: 243-250. 

Smith RA, Berg JE, Pope LE, Callahan JD, Wynn D, Thisted RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004; 10: 679-685.

Starkstein SE, Migliorelli R, Tesón A, et al. Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1995;59:55-60. 

Tang WK, Chan SSM, Chiu HFK, et al. Emotional incontinence in Chinese stroke patients: diagnosis, frequency, and clinical and radiological correlates. J Neurol. 2004;251:865-869.

Tateno A, Jorge RE, Robinson RG. Pathological laughing and crying following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2004; 16: 426-434.

Zeilig G, Drubach DA, Katz-Zeilig M, et al. Pathological laughter and crying in patients with closed traumatic brain injury. Brain Inj. 1996;10:591-597.